ndc for semaglutide Last week's expiry of the patent semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions FDA issues warning about some

Impact of probiotics and prebiotics in the modulation of the major events of the aging process: a systematic review of randomized controlled trials

Seek urgent assessment via NHS 111, eye casualty/A&E, or your GP if you experience: Sudden vision loss or significant deterioration in either eye Floaters (new dark spots or strings drifting through your vision), especially if numerous or increasing Flashes of light in your peripheral vision A curtain or shadow moving across your visual field Distorted vision where straight lines appear wavy or bent Difficulty reading or recognising faces that develops rapidly Blurred vision that doesn't improve with blinking or resting your eyes Eye pain with vision changes or a red, painful eye These symptoms may indicate complications such as vitreous haemorrhage (bleeding into the gel-filled centre of the eye), retinal detachment , or diabetic macular oedema (swelling of the central retina)

Manufactured medications are developed to serve a large population of people and cannot always meet the specific needs of some individuals

Social media creators are swapping smoothie recipes and bragging about hitting 5070 grams a day, way beyond what most people need

Small observational studies and case reports have examined outcomes in patients with type 2 diabetes and concurrent IBD who were prescribed GLP-1 agonists for glycemic control